Valeant Pharma (VRX) CEO Hospitalized with Severe Pneumonia
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Valeant Pharma (VRX) Tests $100 Level as Traders Await Pearson Update
December 29, 2015 11:10 AM ESTValeant Pharma (NYSE: VRX) has taken out yesterday's lows and is testing the $100 level with radio silence from the company about the condition of CEO Mike Pearson. Shares last traded at $100.06, down 2%.
Over the weekend, Pearson was hospitalized for severe pneumonia. Yesterday,... More
Valeant Pharmaceuticals (VRX) Bounces Day After Sharp Drop on CEO Medical Leave
December 29, 2015 9:13 AM ESTAfter dropping 10.5% Monday on news the CEO has been hospitalized with severe pneumonia and has taken an medical leave, Valeant Pharmaceuticals (NYSE: VRX) is up 1.3% this morning as investors bet on a positive outcome and see yesterday's selling as an overreaction.
... MorePershing Square Won't Comment on Valeant Pharma (VRX) CEO Medical Leave News
December 28, 2015 12:24 PM ESTPershing Square offered no comment to StreetInsider on news Valeant Pharma (NYSE: VRX) J. Michael Pearson will be on a medical leave of absence after being hospitalized with a severe case of pneumonia.
"PSCM is not commenting," a spokesperson said.
The... More
Valeant CEO Pearson remains hospitalized for pneumonia: Bloomberg
December 27, 2015 5:00 PM ESTNEW YORK (Reuters) - Valeant Pharmaceuticals International Inc (NYSE: VRX) Chief Executive J. Michael Pearson has been moved to another hospital where he is being treated for a severe case of pneumonia, a company spokeswoman told Bloomberg on Sunday.
Elaine Andrecovich, a public... More
Valeant says CEO J. Michael Pearson hospitalized with severe pneumonia
December 25, 2015 3:16 PM ESTNEW YORK (Reuters) - Valeant Pharmaceuticals International Inc (NYSE: VRX) Chief Executive J. Michael Pearson was hospitalized with a "severe case of pneumonia" on Friday and is receiving treatment, a company spokeswoman said.
"We wish him a speedy recovery and look forward to him returning to work when he is feeling better," the spokeswoman, Laurie Little, said in a statement.
She declined to provide further... More
